Medical Affairs Global Strategic Brand Lead, Ophthalmology

Medical Affairs Global Strategic Brand Lead, Ophthalmology

Join to apply for the Medical Affairs Global Strategic Brand Lead, Ophthalmology role at Astellas Pharma

Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the world.

For more information on Astellas, please visit our website at

This position is based in Northbrook, Illinois. Remote work from certain states may be permitted in accordance with Astellas’ Responsible Flexibility Guidelines. Candidates interested in remote work are encouraged to apply.

The Medical Affairs Global Strategic Brand Lead (MA GSBL) is a core member of the Asset Maximization Team & co‑leads the Global Co‑creation Team (GCT). In collaboration with the Commercial Global Brand Lead (GBL) and Development Asset Lead (AL), the MA GSBL is responsible for driving the global value of a brand. This role focuses on long‑term asset value creation, portfolio strategy, and lifecycle management to achieve the brand’s full potential.

The MA GSBL provides medical input into development of the brand strategy, leads the Core Medical Team (CMT) and facilitates agile Core Medical Plan (CMP) development whilst remaining accountable for delivery of CMP evidence generation and dissemination tactics. The MA GSBL ensures seamless execution of CMP that balances global objectives with local needs and adaptability. As Benefit Risk Team (BRT) chair, the MA GSBL is also responsible for leading, presenting and defending routine and ad‑hoc assessments concerning the Benefit/Risk of the product.

• Lead co‑creation of the Integrated Global Brand Plan (iGBP) with cross‑functional experts and co‑creation affiliates, serving as the brand’s strategic foundation.
• Lead the development of Medical Product Strategy (MPS) and facilitate agile Core Medical Plan (CMP) Development.
• Contribute to creation of Integrated Evidence Generation Plan (iEGP) with cross‑functional experts, serving as the strategic foundation for evidence generation.
• Define and oversee overarching brand objectives with medical KPIs, ensuring alignment with global and local strategies.
• Co‑lead the development of Global Launch Plans. Present to executive leadership at Global Launch Readiness Review meetings, optimizing readiness for an exceptional launch.
• Lead medical input for Lifecycle Management (LCM) strategies and Loss of Exclusivity (LOE) planning to enhance long‑term asset value.

• Lead a high‑impact CMT with accountability for delivery of CMP evidence generation and dissemination tactics, ensuring seamless execution that balances global objectives with local needs and adaptability.
• Accountable for budget management associated with evidence generation and dissemination tactics executed globally.
• Empower & enable affiliates to deliver on non‑evidence generation and dissemination tactics of the CMP, whilst encouraging iterative dialogue to address local needs.
• Overall accountable for all MA evidence generation activities supporting the brand strategy. Activities may be executed by global, regional, or local teams. Lead CMT Study Review Committee (CMT SRC) to ensure robust governance and review of synopsis/protocols of all MA sponsored studies maintaining high standards for evidence generation.
• Accountable for implementation of the Integrated Evidence Dissemination Plan with strong scientific messages to support the brand. Ensure provision of centralized resources and iterative feedback to refine scientific messaging.
• Enable execution of the medical components of the Global launch plan, providing KPIs and metrics to track global progress.
• Responsible for leading, presenting and defending routine and ad‑hoc assessments of the Benefit/Risk of the assigned product. Represent BRT perspective at Global Benefit Risk…